Depression treatment moves from hospital to home
NCT ID NCT05059600
Summary
This study tested whether a 60-hour intravenous treatment for postpartum depression could be safely given at home instead of in a hospital. It involved 52 women with postpartum depression and focused on whether healthcare providers could follow all the safety rules in a home setting. The goal was to see if this treatment could be a more convenient option for new mothers struggling with depression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sage Investigational Site
Culver City, California, 90230, United States
-
Sage Investigational Site
Miramar, Florida, 33029, United States
-
Sage Investigational Site
Pompano Beach, Florida, 33060, United States
-
Sage Investigational Site
New York, New York, 10036, United States
-
Sage Investigational Site
League City, Texas, 77573, United States
-
Virtual Site (recruiting nationwide)
Culver City, California, 90230, United States
Conditions
Explore the condition pages connected to this study.